AMENDED AND RESTATED DEBT CONVERSION AGREEMENTConversion Agreement • May 10th, 2022 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • Florida
This Amended and Restated Debt Conversion Agreement (this “Agreement”) is made effective as of April 29, 2022, by and among H-Cyte, Inc., a Nevada corporation (the “Company”) and the persons and entities listed on Schedule I to this Agreement (collectively, the “Investors” and each, an “Investor”). The Investors and the Company are together referred to as the “Parties” and each a “Party.” All capitalized terms used but not defined in this Agreement have the meanings ascribed to them in (i) the Secured Convertible Note Purchase Agreement dated as of April 1, 2021, by and among the Company and the Investors, as amended by that certain Second Closing Bring-Down Agreement dated as of October 8, 2021, by and among the Company and Investors (as amended, the “Note Purchase Agreement”) and (ii) the Secured Convertible Promissory Notes issued to the Investors pursuant to the Note Purchase Agreement (collectively, the “Tranche 1 Notes”).
